Abstract
Patients with cirrhosis and liver transplantation (LT) have a higher risk of infections, complications and death. Vaccines have historically been used to prevent and reduce the risk of complications from viral and bacterial infections. The population with cirrhosis and candidates for LT should be evaluated for immunity against the most relevant immuno-preventable infections, update corresponding immunizations according to the national vaccination program, and inoculate the missing vaccines based on these recommendations. In case of not reaching its inoculation prior to LT, in the post-LT period its vaccination status should be updated. All doctors involved in the health care of these patients must have knowledge about this important topic and be aware of the access and free availability for this population through the presentation of a special form incorporated into the National Immunization Program.
| Translated title of the contribution | Vaccination for Cirrhosis and Liver Transplant Patients |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 489-496 |
| Number of pages | 8 |
| Journal | Revista Medica de Chile |
| Volume | 151 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2023 |
Bibliographical note
Publisher Copyright:© 2023 Sociedad Medica de Santiago. All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Vaccines
- Fibrosis
- Liver Transplantation
Fingerprint
Dive into the research topics of 'Vaccination for Cirrhosis and Liver Transplant Patients: Puesta al día'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver